GlassScriptPhysician profile
Steven M Rosenberg
NPI 1083610471
$4,089.69
in general payments reported to CMS, 2019-2025
33 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $260 · 2021: $152 · 2022: $206 · 2023: $592 · 2024: $1,057 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,111.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $663.11 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Amgen INC. | $433.88 | 2019-2025 | Otezla, Repatha, Otezla |
| Novo Nordisk INC | $364.00 | 2019-2025 | Wegovy |
| Pfizer INC. | $305.46 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $296.63 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $282.10 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Sanofi-Aventis U.S. LLC | $171.26 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $161.08 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $154.59 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.56 | 2019-2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.47 | 2019-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $85.79 | 2023-2024 | Rexulti |
| Amarin Pharma, INC. | $80.29 | 2019-2020 | |
| Saluda Medical Americas, INC. | $79.60 | 2024 | Evoke |
| Sanofi Pasteur INC. | $77.14 | 2019-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $76.46 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $73.86 | 2019-2025 | Spravato |
| Allergan, INC. | $73.75 | 2019-2020 | |
| Almatica Pharma LLC | $67.74 | 2024 | Loreev Xr |
| Teva Pharmaceuticals USA, INC. | $52.78 | 2019 | |
| Sunovion Pharmaceuticals INC. | $44.80 | 2019-2020 | |
| Inspire Medical Systems, INC. | $40.12 | 2024 | Inspire |
| Bausch Health US, LLC | $39.14 | 2025 | Wellbutrin |
| Regeneron Healthcare Solutions, INC. | $37.13 | 2025 | Dupixent |
| Abbott Laboratories | $33.90 | 2022 | |
| Axsome Therapeutics, INC. | $31.09 | 2025 | Auvelity |
| Sumitomo Pharma America, INC. | $23.38 | 2024 | Gemtesa |
| Radius Health, INC. | $21.74 | 2019 | |
| Lundbeck LLC | $17.51 | 2023 | Rexulti |
| Phathom Pharmaceuticals, INC. | $14.85 | 2024 | Voquezna |
| Idorsia Pharmaceuticals US INC | $14.66 | 2024 | Quviviq |
| Dexcom, INC. | $14.15 | 2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.